Teruaki Okuda

Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

Tomohiro Kaku, Takenori Hitaka, Akio Ojida et al. · Bioorganic & Medicinal Chemistry · 2011 · 126 citations · Full text

Medicinal Chemistry, Selective 17,20-Lyase Inhibitor, Potential Utility +9

High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine

Kenji Yamashita, Hiromi Murakami, Teruaki Okuda et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1996 · 71 citations

Biochemistry, Medicine, Bioanalysis +10

Characterization of the CYP3A4 Active Site by Homology Modeling

Toshimasa Tanaka, Teruaki Okuda, Yoshio Yamamoto · Chemical and Pharmaceutical Bulletin · 2004 · 38 citations

Molecular Docking, Crystal Structure, Drug Target +14

Targeted Therapy for Low Back Pain in Elderly Degenerative Lumbar Scoliosis

Kiyotaka Yamada, Toshio Nakamae, Takuro Shimbo et al. · Spine · 2016 · 32 citations

Bone Marrow Edema and Low Back Pain in Elderly Degenerative Lumbar Scoliosis

Toshio Nakamae, Kiyotaka Yamada, Takuro Shimbo et al. · Spine · 2015 · 28 citations